Mark C. Wiggins, EVP Corporate and Business Development at BIOGEN IDEC INC. (BIIB), sold 5,504 shares at $61.41 ($335K) on 2008-02-12, disclosed to the SEC on 2008-02-15.
Scheduled sale ($335k) by EVP Corporate and Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.56 | 1,218 | $74K | 22.0% |
| 2 | $60.67 | 200 | $12K | 3.6% |
| 3 | $60.69 | 400 | $24K | 7.2% |
| 4 | $60.73 | 100 | $6K | 1.8% |
| 5 | $60.74 | 200 | $12K | 3.6% |
| 6 | $60.81 | 4 |
| $243 |
| 0.1% |
| 7 | $60.82 | 82 | $5K | 1.5% |
| 8 | $60.83 | 400 | $24K | 7.3% |
| 9 | $60.84 | 400 | $24K | 7.3% |
| 10 | $61.00 | 500 | $31K | 9.1% |
| 11 | $61.02 | 500 | $31K | 9.1% |
| 12 | $61.06 | 500 | $31K | 9.1% |
| 13 | $61.12 | 200 | $12K | 3.6% |
| 14 | $61.13 | 200 | $12K | 3.6% |
| 15 | $61.14 | 200 | $12K | 3.7% |
| 16 | $61.17 | 300 | $18K | 5.5% |
| 17 | $61.41 | 100 | $6K | 1.8% |
| Total | $60.87 avg | 5,504 | $335K | 100% |
| Filing → |
| ZGNX | BUY | 2020-03-24 | $51K | — | Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |